The global hyperkalemia treatment market is witnessing substantial growth, driven by an increasing prevalence of chronic diseases such as diabetes and kidney failure. These conditions can lead to high potassium levels in the blood, known as hyperkalemia. The market is further fueled by influences like an aging population, rising healthcare expendit